Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Erie
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Erie, PA

Studies commonly pay $75 to $4,500 per completed study

92 clinical trials are currently recruiting participants within 30 miles of Erie. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

92studies recruiting
4+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Erie right now

Top 25 of 92 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

Diabetic Macular Edema Phase 1 Interventional 93 participants sought
Erie Retina Research, LLC - 300 State St — Erie, Pennsylvania (1.1 mi) · Sponsor: Genentech, Inc.

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: SWOG Cancer Research Network

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigative Site 9924 — Westfield, New York (29.0 mi) · Sponsor: Anthos Therapeutics, Inc.

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Erie, Pennsylvania (1.1 mi) · Sponsor: Medtronic

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration (nAMD) Phase 3 Interventional 480 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: 4D Molecular Therapeutics

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: EyeBiotech Ltd.

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Neovascular (Wet) Age-Related Macular Degeneration Phase 1, Phase 2 Interventional 30 participants sought
Erie, PA — Erie, Pennsylvania (1.1 mi) · Sponsor: Eyconis INC.

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

Dry Age-related Macular Degeneration Phase 3 Interventional 237 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Ocugen

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Cutaneous Melanoma Phase 3 Interventional 428 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Geographic Atrophy Secondary to Age-Related Macular Degeneration Phase 2 Interventional 321 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Genentech, Inc.

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

Center Involved Diabetic Macular Edema, Diabetic Macular Edema Phase 1 Interventional 24 participants sought
Erie Retina Research, LLC — Erie, Pennsylvania (1.1 mi) · Sponsor: Ocugen

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi) · Sponsor: National Cancer Institute (NCI)

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Obesity Phase 2 Interventional 230 participants sought
Great Lakes Medical Research — Westfield, New York (29.0 mi) · Sponsor: Novo Nordisk A/S

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration Phase 1 Interventional 45 participants sought
CBCC Global Research Site:002 — Erie, Pennsylvania (1.1 mi) · Sponsor: Caregen Co. Ltd.

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

Macular Edema Secondary to Inflammation Phase 3 Interventional 300 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: Kodiak Sciences Inc

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Westfield, New York (29.0 mi) · Sponsor: Alnylam Pharmaceuticals

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Diabetic Macular Edema, DME Phase 3 Interventional 240 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi) · Sponsor: EyePoint Pharmaceuticals, Inc.
Actively enrolling

Studies you may be able to join near Erie

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Erie

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Square-1 Clinical Research

2221-A Ebco Dr, Erie, PA 16506
(814) 838-8724

Erie Retina Research

★ 4.8
2005 W 8th St, Erie, PA 16505
(814) 200-9152
"Dr. Almeida is always awesome!"
— Joe Ropelewski, 5★

Susan Hirt Hagen Center for Community Outreach, Research, and Evaluation (CORE)

★ 5.0
5343 Station Rd, Erie, PA 16510
(814) 898-6297
"Great tour today! Props to Hannah, our guide"
— Jeanie Sing, 5★

Great Lakes Medical Research

138 E Main St, Westfield, NY 14787
(716) 326-4890

Clinical trials in Erie: what's recruiting

The Erie area currently has 92 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Erie, the most active research areas are:

  • Cancer & Oncology9 studies
  • Heart & Vascular5 studies
  • Diabetes & Metabolism4 studies
  • Liver & Kidney1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Erie, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Erie

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Erie participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Erie?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Erie safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Erie?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Erie typically complete one or two studies per year.

Paid clinical trials near Erie

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of PA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts